
Journal of Medicinal Chemistry p. 2645 - 2657 (1993)
Update date:2022-08-05
Topics: Potent Conformationally restricted
Clark
Miller
Berger
Repke
Weinhardt
Kowalczyk
Eglen
Bonhaus
Lee
Michel
Smith
Wong
Several series of N-(quinuclidin-3-yl)aryl and heteroaryl-fused pyridones were synthesized and evaluated for 5-HT3 receptor affinity. In the heteroaryl series,2-(quinuclidin-3-yl)tetrahydropyrido[4,3-b]indol-1-one (8a) and the 4,5-alkano-bridge
View MoreContact:--
Address:80G, No.1 Building, Guodu Development Mansion, No. 182 Zhaohui Road, Hangzhou City, Zhejiang Province,China.
FOSHAN NANHAI ZHONGNAN PHARMACEUTICAL FACTORY
Contact:0086-0757-85609331
Address:XIAHENGTIAN INDUSTRIAL ZONE,SHAYONG VILLAGE,LISHUI TOWN
Basilea Pharmaceutica China Ltd.
Contact:+86-513-82198075
Address:No.638 Xiushan Road(East),Haimen, Jiangsu 226100, P.R.China
QINGDAO ON-BILLION INDUSTRAIL CO.,LTD
website:http://www.obn.com.cn
Contact:+86-15005320811 +86-532-80681989
Address:F35 Parkson Mansion No.44-60 Zhongshan Rd.
SHANDONG CREDAGRI CHEMICAL CO., LTD.
Contact:+86-531-88872050
Address:ROOM 601A, BUILDING 2, SHUNTAI SQUARE, NO. 2000 SHUNHUA ROAD, HI-TECH DEVELOPMENT ZONE, JINAN, CHINA.
Doi:10.1016/0040-4039(95)01962-H
(1995)Doi:10.1080/15257779508010707
(1995)Doi:10.1002/anie.201412249
(2015)Doi:10.1021/jo951550w
(1996)Doi:10.1021/acs.jmedchem.9b00711
(2019)Doi:10.1021/ja971901j
(1997)